AIH vs. BACK, ACHC, ICU, BIAF, BIVI, RNXT, JAN, VIRX, ONCT, and OMIC
Should you be buying Aesthetic Medical International Holdings Group stock or one of its competitors? The main competitors of Aesthetic Medical International Holdings Group include IMAC (BACK), Acadia Healthcare (ACHC), SeaStar Medical (ICU), bioAffinity Technologies (BIAF), BioVie (BIVI), RenovoRx (RNXT), JanOne (JAN), Viracta Therapeutics (VIRX), Oncternal Therapeutics (ONCT), and Singular Genomics Systems (OMIC). These companies are all part of the "medical" sector.
Aesthetic Medical International Holdings Group (NASDAQ:AIH) and IMAC (NASDAQ:BACK) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.
In the previous week, IMAC had 17 more articles in the media than Aesthetic Medical International Holdings Group. MarketBeat recorded 19 mentions for IMAC and 2 mentions for Aesthetic Medical International Holdings Group. Aesthetic Medical International Holdings Group's average media sentiment score of 1.61 beat IMAC's score of 0.15 indicating that Aesthetic Medical International Holdings Group is being referred to more favorably in the media.
2.1% of Aesthetic Medical International Holdings Group shares are held by institutional investors. Comparatively, 5.8% of IMAC shares are held by institutional investors. 55.1% of Aesthetic Medical International Holdings Group shares are held by insiders. Comparatively, 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Aesthetic Medical International Holdings Group has higher revenue and earnings than IMAC.
Aesthetic Medical International Holdings Group has a net margin of 0.00% compared to IMAC's net margin of -176.22%. Aesthetic Medical International Holdings Group's return on equity of 0.00% beat IMAC's return on equity.
Aesthetic Medical International Holdings Group has a beta of -0.21, suggesting that its share price is 121% less volatile than the S&P 500. Comparatively, IMAC has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500.
Aesthetic Medical International Holdings Group received 1 more outperform votes than IMAC when rated by MarketBeat users. Likewise, 33.33% of users gave Aesthetic Medical International Holdings Group an outperform vote while only 0.00% of users gave IMAC an outperform vote.
Summary
Aesthetic Medical International Holdings Group beats IMAC on 9 of the 13 factors compared between the two stocks.
Get Aesthetic Medical International Holdings Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aesthetic Medical International Holdings Group Competitors List
Related Companies and Tools
